Highlighted: Chronic kidney disease and stroke risk, syphilis in ESRD patients, and how healthy diets may reduce CKD incidence.
Andrew D. Bowser
Three new studies on ADPKD treatment project long-term impact of tolvaptan; reveal potential in an existing drug class; and, report success in slowing comorbid hepatic disease.
Most children with ADPKD remain asymptomatic, but some manifest early and aggressive disease. Try our 6 questions on the new expert guidance on tricky treatment issues.
Autosomal dominant polycystic kidney disease is the most common form of polycystic renal disease. Find out what you know about ADPKD with this 7-question quiz on epidemiology, diagnosis, and more.
The primary care role in detection, management, and reducing the risk of progression of CKD continues to expand. Test yourself here on basics in each category.
Keeping a loop diuretic on board during dialysis could be an effective, low-cost option to help improve patient outcomes, according to a new study.
How much do you know about HCV treatment in children and teens? Take this short, 5-question quiz to find out.
Study summaries highlight increased infection rates in young adults; a spike in HCV in reproductive-aged women; and a potential new treatment for HCV in young children.
ICYMI: HCV elimination success, SVR in blacks, transplant delisting, clearance after acute infection—catch up with a quiz.
Can DAA therapy remove patients from transplant waiting lists? Are HCV-infected livers--and hearts--safe for uninfected organ recipients? Three new studies explain.